Aerobiotix

Aerobiotix, Inc. specializes in advanced air quality management solutions for the healthcare market. The company develops and manufactures medical-grade air treatment and monitoring systems aimed at improving healthcare environments by reducing airborne pathogens and enhancing patient safety. Their products utilize technologies such as ultraviolet (UV) light and HEPA and ULPA filters to eliminate airborne viruses, bacteria, and spores. A key offering is the Illuvia 500UV, a HEPA Ultraviolet Air Recirculation System that effectively eliminates 99% of bacteria and spore-related viruses in a single pass. Aerobiotix focuses on delivering safe and effective air quality products that meet stringent healthcare standards, providing measurable insights to support patient care and environmental safety. The company serves a range of customers, including hospitals, healthcare facilities, assisted living centers, and educational institutions. Aerobiotix is committed to reducing airborne infection risks and enhancing overall healthcare quality and safety.

• Employees 33
• Founded 2013
• Annual Revenue $4000000
• Total Funding $35000000